Most chronic pain patients in Ohio were willing to try medical marijuana and wanted to reduce opioid use
Among 242 chronic pain patients surveyed in Ohio, 84% were willing to consider medical marijuana, 68% wanted to use less opioids, and 94% would follow their pain specialist's recommendations about concurrent use.
Quick Facts
What This Study Found
84.3% were willing to consider medical marijuana. 67.6% wanted to use fewer opioids after starting MMJ. 93.6% were amenable to following their specialist's recommendations about concurrent opioid-MMJ use. The greatest concern was affordability (2.98/5). Older patients were less likely to prefer inhaled forms (p=0.023).
Key Numbers
242 respondents from 1,047 invited (23.1%). Average age 51-60. 70.7% female. 60.7% on opioids. 84.3% willing to consider MMJ. 67.6% wanted less opioid use. 93.6% would follow specialist guidance. Affordability top concern (2.98/5).
How They Did This
Online survey (MMIQ) administered to 1,047 chronic pain patients at a pain medicine center in Ohio. 242 responses (23.1%). Average age 51-60 years, 70.7% female, 60.7% current opioid users. Assessed willingness, compliance intent, and concerns.
Why This Research Matters
In a region heavily affected by the opioid crisis, chronic pain patients' overwhelming willingness to try medical marijuana and reduce opioid use suggests strong patient demand for cannabis as a pain management option.
The Bigger Picture
The high willingness to follow provider recommendations suggests an opportunity for pain specialists to guide medical marijuana integration into treatment plans, potentially reducing opioid reliance with appropriate oversight.
What This Study Doesn't Tell Us
Low response rate (23.1%) with online-only administration likely skewing toward younger, more tech-savvy patients. Single clinic in Ohio. Patients not yet using MMJ, so attitudes may differ from actual behavior. Self-reported willingness may overestimate real-world compliance.
Questions This Raises
- ?Do patients who express willingness actually follow through with MMJ?
- ?Does MMJ use actually reduce opioid consumption in this population?
- ?What barriers prevent willing patients from accessing medical marijuana?
Trust & Context
- Key Stat:
- 84% of chronic pain patients willing to try medical marijuana
- Evidence Grade:
- Well-designed survey capturing patient attitudes, but low response rate and single-site limit generalizability.
- Study Age:
- 2021 study from Ohio, which legalized medical marijuana in 2018. Reflects early patient attitudes in a newly legalized state.
- Original Title:
- Interests and concerns regarding medical marijuana among chronic pain patients in Ohio: an online survey.
- Published In:
- Journal of cannabis research, 3(1), 37 (2021)
- Authors:
- Adams, Daniel, Ofei-Tenkorang, Nana Ama, Connell, Patrick, Owens, Alexa, Gothard, Aaron, Souza, Dmitri, Narouze, Samer
- Database ID:
- RTHC-02946
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
What was patients' biggest concern about medical marijuana?
Affordability was the top concern (rated 2.98 out of 5). Medical marijuana is typically not covered by insurance, making cost a significant barrier for chronic pain patients.
Did age affect preferences?
Yes. Older patients were significantly less likely to prefer inhaled forms of medical marijuana, suggesting that dosing form options matter for different age groups.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBD-oil-quality-guide
- CBT-cannabis-recovery
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cannabis-relapse-cycle-pattern
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- medical-benefits-of-cannabis
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-before-surgery
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- seniors-older-adults-cannabis-risks-medications
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-breastfeeding-THC-breast-milk
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-02946APA
Adams, Daniel; Ofei-Tenkorang, Nana Ama; Connell, Patrick; Owens, Alexa; Gothard, Aaron; Souza, Dmitri; Narouze, Samer. (2021). Interests and concerns regarding medical marijuana among chronic pain patients in Ohio: an online survey.. Journal of cannabis research, 3(1), 37. https://doi.org/10.1186/s42238-021-00092-y
MLA
Adams, Daniel, et al. "Interests and concerns regarding medical marijuana among chronic pain patients in Ohio: an online survey.." Journal of cannabis research, 2021. https://doi.org/10.1186/s42238-021-00092-y
RethinkTHC
RethinkTHC Research Database. "Interests and concerns regarding medical marijuana among chr..." RTHC-02946. Retrieved from https://rethinkthc.com/research/adams-2021-interests-and-concerns-regarding
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.